Page 1 of Clinical Trials for Adenocarcinoma of Gall Bladder or Biliary Ducts, 55 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Last Updated: December 27, 2011
Condition(s): Cholangiocarcinoma
2
Completed
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Last Updated: June 29, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
3
Completed
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery
Last Updated: December 13, 2011
Condition(s): Bile Duct Neoplasms; Gallbladder Cancer
4
Active, not recruiting
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
Last Updated: November 26, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
5
Recruiting
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Last Updated: November 3, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Pancreatic Cancer; Periampullary Adenocarcinoma; Small Intestine Cancer
6
Recruiting
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
Last Updated: March 10, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
7
Completed
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Last Updated: January 18, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
8
Active, not recruiting
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Last Updated: February 6, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Pain
9
Recruiting
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
Last Updated: November 2, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
10
Completed
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
Last Updated: February 6, 2009
Condition(s): Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
11
Active, not recruiting
S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Last Updated: July 13, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
12
Suspended
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Last Updated: March 29, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
13
Active, not recruiting
S0202 Gemcit. and Capecit. for Pts w/Unresect Locally Adv Met Gallbladder Cancer or Cholangiocarcinoma
Last Updated: July 13, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
14
Active, not recruiting
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
Last Updated: October 17, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
15
Completed
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
Last Updated: August 7, 2009
Condition(s): Biliary Tract Adenocarcinoma; Gallbladder Adenocarcinoma
16
Active, not recruiting
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer
Last Updated: July 23, 2008
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
17
Active, not recruiting
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Last Updated: May 27, 2010
Condition(s): Cancer
18
Completed
Gene Therapy in Treating Patients With Cancer
Last Updated: June 9, 2011
Condition(s): Cancer
19
Active, not recruiting
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
Last Updated: August 31, 2010
Condition(s): Cancer
20
Recruiting
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
Last Updated: September 20, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Periampullary Adenocarcinoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Adenocarcinoma+of+Gall+Bladder+or+Biliary+Ducts

Page 1 of Clinical Trials for Adenocarcinoma of Gall Bladder or Biliary Ducts, 55 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About